Serial founder
Manchester University spin-out C4X Discovery Holdings plc has a new CEO. UK biotech notable Clive Dix has taken over the helm of the UK drug discovery company. Dix joined C4XD as Non-Executive Chairman in October 2014 and became Executive Chairman in November 2015.
Before that, he was the co-founder and CEIO of Convergence Pharmaceuticals, which was acquired by Biogen last year. Previously, Dix founded PowderMed, a vaccines development company. He currently serves as Chairman of Touchlight Genetics and Centauri Therapeutics, and was Chairman of the UK BioIndustry Association from 2008-2010.
pixabay.com - geralt
SK Bioscience
wikioedia.org - Von http://web2.airmail.net/uthman/specimens/index.html, Gemeinfrei, https://commons.wikimedia.org/w/index.php?curid=841015